Characterized by adverse reactions to the infusion of pharmacologic or biologic substances, described as infusion reactions. 1Â
1 Schneider, B. J., Naidoo, J., Santomasso, B. D., Lacchetti, C., Adkins, S., Anadkat, M., ... & Bollin, K. (2021). Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update. Journal of Clinical Oncology, 39(36), 4073-4126.